Thiago Carvalho @cyrilpedia@social.cleverlibre.org

Second try!
#Science #Introduction
Based in beautiful #Lyon #France we study #bacterial #pathogens

Our focus: the intracellular sneaky pathogen #Brucella abortus; and the multi-drug resistant (not so sneaky) #Acinetobacter baumannii.

We want to know how they interact with cells, how they hide inside and what they inject into them to make all this happen.

This is our lab account, an international, inclusive, fun team with #microbiology, #InfectionBiology and #biochemistry expertise

We’re looking for in vivo rodent electrophysiologists interested in complex behaviour to come and work in beautiful Glasgow. Advert to appear shortly, but meanwhile, if you’re interested and will be at at #sfn2022, come and find me! (Both postdoc and tenured positions available)a

@shrewshrew “Is there anybody on this plane who knows why mice bury marbles and DIDN’T have the fish for dinner?”

We study pulmonary #immunity to #Tuberculosis and
#influenza. We used to focus on T cells but now it's pretty much any/everything We believe in #openscience (and love #biorxiv)

Hey there! I am an #academic in the area of animal #infectious #disease. I work mainly with mosquito-borne viruses and multi-strain #pathogens. Currently I am a PI at BioISI/FCUL of the University of Lisbon. New to this platform. Am on Twitter as well @lourencoJML #introduction

We are recruiting lecturers in a wide range of topics in Biology including developmental/stem cell biology, #mechanobiology and single cell #omics approaches-come and join us! Deadline: 19th December 2022
More details here: https://www.jobs.ac.uk/job/CUV141/lecturer

Hello! By way of introduction, here are some of our recent papers / preprints!

1) A preprint on high-res promoter interaction analysis in a rare cell type (type 3 Innate lymphoid cells) and using these data for linking Crohn's GWAS variants with target genes:

https://www.biorxiv.org/content/10.1101/2022.10.19.512842v3

2) A protocol article on Capture Hi-C analysis using the tools we (and others) developed:

https://www.nature.com/articles/s41596-021-00567-5

3) A review about enhancers and enhancer-promoter communication:

https://link.springer.com/article/10.1007/s00018-021-03903-w

I gotta admit, this one stings!

Ah yes that BS again #nhs #medtwitter

Soon he’ll be bringing in Deloitte et al and palantir who will run some “data” get paid gazillions and rename a few departments, leaving it a bigger mess than it is

https://www.theguardian.com/society/2022/nov/13/jeremy-hunt-nhs-brink-collapse-efficiencies-must-be-found?CMP=Share_iOSApp_Other

#introductions

Hi Mastodonians!

I am an oncologist and scientist at the NCI developing #radiopharmaceuticals in the lab to help image and treat human cancers.

My research sits at the interface of #oncology #chemistry #radiochemistry #drugdevelopment #clinicaltrials #nucmed #radonc.

Beyond the professional, I enjoy #audiobooks, #fitness, #coffee, and occasional #beer #homebrewing.

Looking to connect with and learn from diverse thinkers in oncology, medicine, and beyond.

So I am an epidemiologist, but the best part of my job is collaborating with legal colleagues Amy Kapczynski and Ali Miller as part of the YSPH/YLS Global Health Justice Partnership! https://law.yale.edu/ghjp/about-us

Hello #ScienceMastodon.

I am a 5th year PhD Immunology student at UAlberta🇨🇦 studying glycosylation, B cells, and antibodies. I also dabbled with glycan-mediated macrophage-T cell interactions. Looking forward to great #Immunology #glycotime #virology #cancer discussions here!